Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome (MDS)/AML · Proton Therapy · MDS and AML Prior to Allogeneic SCT · Myelodysplastic Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Institute of Hematology and Blood Transfusion, Prague, Czechia
Contact: Study coordinator (Veronika Valkova, Assoc.Prof., MD, PhD) · Veronika.Valkova@uhkt.cz · +420 221 977 301Contact: Principal Investigator (Veronika Valkova, Assoc.Prof., MD, PhD.)Proton Therapy Center Czech, Prague, Czechia